scispace - formally typeset
J

Jeffrey W. Miller

Researcher at Harvard University

Publications -  42
Citations -  1481

Jeffrey W. Miller is an academic researcher from Harvard University. The author has contributed to research in topics: Bayesian probability & Bayesian inference. The author has an hindex of 16, co-authored 39 publications receiving 1086 citations. Previous affiliations of Jeffrey W. Miller include Brown University.

Papers
More filters
Journal ArticleDOI

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

Andrew J. Aguirre, +89 more
- 14 Jun 2018 - 
TL;DR: Using an integrated multidisciplinary biopsy program, it is demonstrated that real-time genomic characterization of advanced PDAC can identify clinically relevant alterations that inform management of this difficult disease.
Journal ArticleDOI

Robust Bayesian Inference via Coarsening

TL;DR: This work introduces a novel approach to Bayesian inference that improves robustness to small departures from the model: rather than conditioning on the event that the observed data are generated by the model, one conditions on theevent that the model generates data close to the observedData, in a distributional sense.
Journal ArticleDOI

Mixture Models With a Prior on the Number of Components

TL;DR: The most commonly used method of inference for MFMs is reversible jump Markov chain Monte Carlo, but it can be nontrivial to design good reversible jump moves, especially in high-dimensional spaces as discussed by the authors.
Posted Content

Mixture models with a prior on the number of components

TL;DR: It turns out that many of the essential properties of DPMs are also exhibited by MFMs, and the MFM analogues are simple enough that they can be used much like the corresponding DPM properties; this simplifies the implementation of MFMs and can substantially improve mixing.
Journal ArticleDOI

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

Robert C. Green, +230 more
TL;DR: The CSER consortium is exploring analytic and clinical validity and utility, as well as the ethical, legal, and social implications of sequencing via multidisciplinary approaches; it has recruited 5,577 participants across a spectrum of symptomatic and healthy children and adults by utilizing both germline and cancer sequencing.